Impact of Hepatitis C Viremic Lung Donors on Waitlist Time and Outcomes in High-Risk Recipients

Purpose: Despite the advent of direct acting antivirals (DAA), the Hepatitis C viremic (HCV+) donors remain an untapped pool. Furthermore, published studies to date have been limited to successful outcomes in low risk profile candidates. Here, we report a case series of lung transplantation (LTx) from HCV+ donors into a cohort that includes: 1) Critically ill patients with high allocation score (LAS/CAS) on ECMO and mechanical ventilation, 2) Highly sensitized patients, and 3) Patients at risk for malabsorption.

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , J. Chen, M. Brzezinski, J. Price, B. Trinh, T. Deuse, R. Florez, S. Hays, L. Leard, J. Golden, J. Singer, J. Kukreja Source Type: research